Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4id7 | 1G0 | Activated CDC42 kinase 1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 1.000 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.528 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.525 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.520 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.519 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.516 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.515 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.513 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.508 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.505 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.505 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.500 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.498 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.497 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.495 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.492 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.491 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.488 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.487 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.485 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.485 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.483 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.482 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.478 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.475 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.475 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.475 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.474 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.473 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.472 | |
2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.470 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.469 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.469 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.469 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.466 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
3erk | SB4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.466 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.465 | |
3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.465 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.464 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.464 | |
2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.461 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.461 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.460 | |
2yxu | ATP | Pyridoxal kinase | 2.7.1.35 | 0.459 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.458 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.458 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.458 | |
3fhy | ATP | Pyridoxal kinase | 2.7.1.35 | 0.457 | |
2b9w | FAD | Putative aminooxidase | / | 0.456 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.456 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.456 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.456 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.455 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.453 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.453 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.453 | |
4en4 | ATP | Pyridoxal kinase | 2.7.1.35 | 0.453 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.453 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.452 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
3mg3 | ECH | Orange carotenoid-binding protein | / | 0.452 | |
3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.452 | |
4q73 | FAD | Bifunctional protein PutA | / | 0.452 | |
5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.452 | |
1zmd | NAI | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.451 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.450 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.450 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.450 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.450 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
1hdc | CBO | 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase | 1.1.1.53 | 0.448 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.448 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
3ics | COA | Coenzyme A disulfide reductase | / | 0.448 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.447 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.447 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
3vth | APC | Carbamoyltransferase | / | 0.447 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
4wlv | NAD | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.447 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
4wlu | NAD | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.446 | |
5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.446 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.445 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.445 | |
1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.444 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.444 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.444 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
1npt | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.442 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.442 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.442 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.442 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.442 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.441 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
4d9t | 0JG | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.441 | |
4gyi | ADP | Uncharacterized protein | / | 0.441 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.441 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.441 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.441 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.441 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.440 | |
4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.440 |